Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression
- 29 September 2004
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 6 (3), 297-305
- https://doi.org/10.1016/j.ccr.2004.08.012
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Mediation of Transforming Growth Factor-β1-Stimulated Matrix Contraction by FibroblastsThe American Journal of Pathology, 2003
- Inflammation and cancerNature, 2002
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland DevelopmentCell, 2001
- Series Introduction: The transcription factor NF-κB and human diseaseJCI Insight, 2001
- Safety and antitumor activity of recombinant soluble Apo2 ligandJCI Insight, 1999
- Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)Science, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- Mapping of the Inducible IκB Phosphorylation Sites That Signal Its Ubiquitination and Degradation†Molecular and Cellular Biology, 1996